Biomerica Inc Total Assets
Biomerica Inc total assets. Based on the latest financial reports, Biomerica Inc (BMRA) holds total assets worth $6.76 Million USD as of May 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BMRA market cap for the company's overall valuation and market capitalisation.
Total Assets of Biomerica Inc (1986–2026)
Total assets of Biomerica Inc from 1986 to 2026. This chart illustrates how Biomerica Inc's total assets have evolved over time, based on quarterly financial data. See BMRA share price today for real-time trading data and today's change.
Biomerica Inc - Asset Composition Analysis
Biomerica Inc Total Assets Breakdown (May 2026)
Biomerica Inc total assets breakdown as of May 2026. Biomerica Inc's total assets of $6.76 Million consist of 59.4% current assets and 40.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 19.4% |
| Accounts Receivable | $785.00K | 11.6% |
| Inventory | $1.71 Million | 25.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $209.00K | 3.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1986–2026)
This chart illustrates how Biomerica Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Biomerica Inc to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Biomerica Inc's current assets represent 59.4% of total assets in 2026, a decrease from 94.7% in 1986.
- Cash Position: Cash and equivalents constituted 19.4% of total assets in 2026, down from 82.7% in 1986.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 1986.
- Asset Diversification: The largest asset category is inventory at 25.3% of total assets.
Biomerica Inc Competitors by Total Assets
Key competitors of Biomerica Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Biomerica Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.62 | 2.80 | 6.04 |
| Quick Ratio | 0.93 | 1.95 | 4.10 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.53 Million | $3.13 Million | $7.46 Million |
Biomerica Inc - Advanced Valuation Insights
This section examines the relationship between Biomerica Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.89 |
| Latest Market Cap to Assets Ratio | 1.15 |
| Asset Growth Rate (YoY) | 13.7% |
| Total Assets | $6.76 Million |
| Market Capitalization | $7.80 Million USD |
Valuation Analysis
Above Book Valuation: The market values Biomerica Inc's assets above their book value (1.15x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Biomerica Inc's assets grew by 13.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Biomerica Inc (1986–2026)
The table below shows the annual total assets of Biomerica Inc from 1986 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-05-31 | $6.76 Million | +13.69% |
| 2025-05-31 | $5.95 Million | -35.76% |
| 2024-05-31 | $9.25 Million | -35.98% |
| 2023-05-31 | $14.45 Million | +27.08% |
| 2022-05-31 | $11.37 Million | -3.76% |
| 2021-05-31 | $11.82 Million | -31.52% |
| 2020-05-31 | $17.26 Million | +229.05% |
| 2019-05-31 | $5.25 Million | +0.44% |
| 2018-05-31 | $5.22 Million | +4.08% |
| 2017-05-31 | $5.02 Million | -12.37% |
| 2016-05-31 | $5.73 Million | -6.50% |
| 2015-05-31 | $6.12 Million | -5.35% |
| 2014-05-31 | $6.47 Million | +1.18% |
| 2013-05-31 | $6.39 Million | +14.79% |
| 2012-05-31 | $5.57 Million | +12.42% |
| 2011-05-31 | $4.96 Million | -1.19% |
| 2010-05-31 | $5.02 Million | -2.66% |
| 2009-05-31 | $5.15 Million | +0.87% |
| 2008-05-31 | $5.11 Million | +58.40% |
| 2007-05-31 | $3.22 Million | +32.79% |
| 2006-05-31 | $2.43 Million | -58.07% |
| 2005-05-31 | $5.79 Million | +4.00% |
| 2004-05-31 | $5.57 Million | +0.36% |
| 2003-05-31 | $5.55 Million | +5.14% |
| 2002-05-31 | $5.28 Million | -1.32% |
| 2001-05-31 | $5.35 Million | -20.61% |
| 2000-05-31 | $6.74 Million | -13.65% |
| 1999-05-31 | $7.80 Million | +4.00% |
| 1998-05-31 | $7.50 Million | +1.35% |
| 1997-05-31 | $7.40 Million | +21.31% |
| 1996-05-31 | $6.10 Million | +5.17% |
| 1995-05-31 | $5.80 Million | -7.94% |
| 1994-05-31 | $6.30 Million | 0.00% |
| 1993-05-31 | $6.30 Million | -1.56% |
| 1992-05-31 | $6.40 Million | -12.33% |
| 1991-05-31 | $7.30 Million | -18.89% |
| 1990-05-31 | $9.00 Million | +136.84% |
| 1989-05-31 | $3.80 Million | -20.83% |
| 1988-05-31 | $4.80 Million | -23.81% |
| 1987-05-31 | $6.30 Million | -16.00% |
| 1986-05-31 | $7.50 Million | -- |
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients… Read more